| Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity ML Choi, A Chappard, BP Singh, C Maclachlan, M Rodrigues, ... Nature neuroscience 25 (9), 1134-1148, 2022 | 96 | 2022 |
| The impact of type 2 diabetes in Parkinson's disease D Athauda, J Evans, A Wernick, G Virdi, ML Choi, M Lawton, ... Movement Disorders 37 (8), 1612-1623, 2022 | 46 | 2022 |
| Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease S Koga, F Li, N Zhao, SF Roemer, TJ Ferman, AI Wernick, RL Walton, ... Brain Pathology 30 (4), 766-778, 2020 | 24 | 2020 |
| Multiple system atrophy and apolipoprotein E K Ogaki, YA Martens, MG Heckman, S Koga, C Labbé, ... Movement Disorders 33 (4), 647-650, 2018 | 20 | 2018 |
| Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons GS Virdi, ML Choi, JR Evans, Z Yao, D Athauda, S Strohbuecker, ... npj Parkinson's Disease 8 (1), 162, 2022 | 17 | 2022 |
| GBA variation and susceptibility to multiple system atrophy AI Wernick, RL Walton, S Koga, AI Soto-Beasley, MG Heckman, Z Gan-Or, ... Parkinsonism & Related Disorders 77, 64-69, 2020 | 14 | 2020 |
| Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy AI Wernick, RL Walton, AI Soto-Beasley, S Koga, MG Heckman, ... Clinical Autonomic Research 31, 117-125, 2021 | 11 | 2021 |
| The annotation and function of the Parkinson’s and Gaucher disease-linked geneGBA1has been concealed by its protein-coding pseudogeneGBAP1 EK Gustavsson, S Sethi, Y Gao, JW Brenton, S García-Ruiz, D Zhang, ... | 7* | 2022 |
| Spinocerebellar ataxia type 6 family with phenotypic overlap with Multiple System Atrophy RH Al-Shaikh, AI Wernick, AJ Strongosky, AI Soto-Beasley, ... Neurologia i neurochirurgia polska 54 (4), 350-355, 2020 | 6 | 2020 |
| Investigating ELOVL7 coding variants in multiple system atrophy AI Wernick, RL Walton, AI Soto-Beasley, S Koga, Y Ren, MG Heckman, ... Neuroscience letters 749, 135723, 2021 | 2 | 2021 |
| Structural conversion of α-synuclein at the mitochondria induces neuronal toxicity ML Choi, A Chappard, BP Singh, C Maclachlan, M Rodrigues, E Fedotova, ... bioRxiv, 2022.06. 07.494932, 2022 | 1 | 2022 |
| An Examination of the Effect of Neuronal Beta-Glucocerebrosidase Dysfunction, and the Search for Endogenous Regulators AI Wernick UCL (University College London), 2024 | | 2024 |
| GLP-1 receptor agonism ameliorates Parkinsons disease through modulation of neuronal insulin signalling and glial suppression D Athauda, JR Evans, L Sanchez, G Virdi, P Lopez Garcia, A Wernick, ... bioRxiv, 2024.02. 28.582460, 2024 | | 2024 |
| Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity (Oct, 10.1038/s41593-022-01140-3, 2022) ML Choi, A Chappard, BP Singh, C Maclachlan, M Rodrigues, ... NATURE NEUROSCIENCE 25 (11), 1582-1582, 2022 | | 2022 |
| Protein aggregation and calcium dysregulation are the earliest hallmarks of synucleinopathy in human midbrain dopaminergic neurons GS Virdi, ML Choi, JR Evans, Z Yao, D Athauda, S Strohbuecker, ... bioRxiv, 2022.10. 28.514238, 2022 | | 2022 |
| Exenatide protects iPSC-derived dopaminergic neurons with A53T mutation through restoration of insulin signaling D Athauda, J Evans, A Wernick, G Virdi, M Choi, K D'Sa, Z Shadman, ... MOVEMENT DISORDERS 37, S587-S587, 2022 | | 2022 |
| Investigation of Modifiers of beta-Glucocerebrosidase in Cell Models of Parkinson's Disease A Wernick, J Evans, G Virdi, M Choi, D Athauda, ZZ Shadman, ... MOVEMENT DISORDERS 37, S582-S583, 2022 | | 2022 |
| Variants in the beta-Glucocerebrosidase A (GBA) gene in German patients with Parkinson's disease A Deutschlander, A Wernick, R Walton, A Soto, O Ross, Z Wszolek MOVEMENT DISORDERS 34, S174-S175, 2019 | | 2019 |
| Apolipoprotein E and multiple system atrophy K Ogaki, Y Martens, M Heckman, S Koga, L Labbe, O Lorenzo-Betancor, ... MOVEMENT DISORDERS 33, S418-S418, 2018 | | 2018 |
